Deutsche Apotheker- und Arztebank:企業の戦略・SWOT・財務分析

◆英語タイトル:Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3597
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Deutsche Apotheker- und Arztebank – Strategy, SWOT and Corporate Finance Report
Summary

Deutsche Apotheker- und Arztebank – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Deutsche Apotheker- und Arztebank (Apobank) is a cooperative bank that offers retail and corporate banking services with the focus on healthcare sector. It provides checking accounts, practice accounts, student council accounts, cards, consultation, funding, insurance, pensions, finance, fixed deposits, call money, and private banking services. The bank also offers interest and currency management, business banking, asset management services, custodian service, investment consulting, portfolio management, and credit analysis to institutional investors. It works with professional associations to support inter-professional exchange, decision making, fee payments handling, and provides investment advices. It operates through branches and advisory offices in Germany. Apobank is headquartered in Dusseldorf, Germany.

Scope

- Detailed information on Deutsche Apotheker- und Arztebank required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Deutsche Apotheker- und Arztebank in the form of a SWOT analysis
- An in-depth view of the business model of Deutsche Apotheker- und Arztebank including a breakdown and examination of key business segments
- Intelligence on Deutsche Apotheker- und Arztebank’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Deutsche Apotheker- und Arztebank, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Deutsche Apotheker- und Arztebank and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Deutsche Apotheker- und Arztebank as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Deutsche Apotheker- und Arztebank’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Deutsche Apotheker- und Arztebank: Company Overview
Deutsche Apotheker- und Arztebank: Overview and Key Facts
Deutsche Apotheker- und Arztebank: Overview
Deutsche Apotheker- und Arztebank: Key Facts
Deutsche Apotheker- und Arztebank: Key Employees
Deutsche Apotheker- und Arztebank: Key Employee Biographies
Deutsche Apotheker- und Arztebank: Major Products and Services
Deutsche Apotheker- und Arztebank: Company History
Deutsche Apotheker- und Arztebank: Management Statement
Deutsche Apotheker- und Arztebank: Locations and Subsidiaries
Deutsche Apotheker- und Arztebank: Key Competitors
Deutsche Apotheker- und Arztebank: Company Analysis
Deutsche Apotheker- und Arztebank: Business Description
Deutsche Apotheker- und Arztebank: SWOT Analysis
Deutsche Apotheker- und Arztebank: SWOT Overview
Deutsche Apotheker- und Arztebank: Strengths
Deutsche Apotheker- und Arztebank: Weaknesses
Deutsche Apotheker- und Arztebank: Opportunities
Deutsche Apotheker- und Arztebank: Threats
Deutsche Apotheker- und Arztebank: Corporate Financial Deals Activity
Deutsche Apotheker- und Arztebank: Financial Deals Overview
Deutsche Apotheker- und Arztebank: Top Deals 2015 – 2019YTD*
Deutsche Apotheker- und Arztebank: Advisors
Deutsche Apotheker- und Arztebank: Top Financial Advisors
Deutsche Apotheker- und Arztebank: Capital Raising
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Deutsche Apotheker- und Arztebank: Key Facts
Table 2: Deutsche Apotheker- und Arztebank: Key Employees
Table 3: Deutsche Apotheker- und Arztebank: Company History
Table 4: Deutsche Apotheker- und Arztebank: Locations and Subsidiaries
Table 5: Deutsche Apotheker- und Arztebank: Key Competitors
Table 6: Deutsche Apotheker- und Arztebank: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Deutsche Apotheker- und Arztebank: Top Deals 2015 - 2019YTD*
Table 8: Deutsche Apotheker- und Arztebank: Financial Advisor Ranking by Value (US$m)
Table 9: Deutsche Apotheker- und Arztebank: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 10: Deutsche Apotheker- und Arztebank: Capital Raising by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Deutsche Apotheker- und Arztebank:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Yurun Food Group Limited:企業の戦略・SWOT・財務情報
    China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Yurun Food Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Oil and Natural Gas Corporation Limited:企業の戦略・SWOT・財務分析
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Active Motif Inc-製薬・医療分野:企業M&A・提携分析
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products comprise antibodies, extracts, fluorescent dyes, kits, reporter assays, molecules and recombinant proteins. It offers products for transcriptional regulation, …
  • Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • Verseon Corp (VSN):企業の財務・戦略的SWOT分析
    Summary Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardi …
  • Everest Industries Ltd:企業の戦略・SWOT・財務情報
    Everest Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Everest Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AVI Ltd:企業の戦略・SWOT・財務分析
    AVI Ltd - Strategy, SWOT and Corporate Finance Report Summary AVI Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Samart Corporation Public Co Ltd (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Public Co Ltd (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Bose Corporation:企業の戦略・SWOT・財務情報
    Bose Corporation - Strategy, SWOT and Corporate Finance Report Summary Bose Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Typhoon Exploration Inc (TYP):企業の財務・戦略的SWOT分析
    Summary Typhoon Exploration Inc (Typhoon Exploration) is a mineral exploration company. The company carries out acquisition, exploration and development of gold assets. It provides technology for exploration projects. Typhoon Exploration’s operational areas include Monexco, Fayolle, Faille 1, Destor …
  • PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEngine Inc (PharmaEngine) is a biopharmaceutical company that discovers and develops cancer treatment drugs and related medicinal products. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products include Onivyde a liposome encapsulation of irin …
  • Sandoz International GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio …
  • The British United Provident Association Ltd-製薬・医療分野:企業M&A・提携分析
    Summary The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing home …
  • Poudre Valley Rural Electric Association, Inc.:発電所・企業SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. It provides products such as Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with …
  • Enable Midstream Partners LP (ENBL):石油・ガス:M&Aディール及び事業提携情報
    Summary Enable Midstream Partners, LP (Enable), a subsidiary of CenterPoint Energy Inc, owns, operates, and develops natural gas and crude oil infrastructure assets. It is a limited partnership among CenterPoint Energy, OGE Energy and ArcLight Capital Partners, LLC. The company offers crude oil and …
  • Ageas NV:企業の戦略・SWOT・財務情報
    Ageas NV - Strategy, SWOT and Corporate Finance Report Summary Ageas NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Cell Signaling Technology Inc-医療機器分野:企業M&A・提携分析
    Summary Cell Signaling Technology Inc (CST) is a biotechnology company that develops and manufactures antibody products for medical research and clinical diagnostic market. The company products include primary antibodies, antibody samplers, secondary antibodies, antibody conjugates, ELISA Kits, anti …
  • IV Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • ERG SpA (ERG):電力:M&Aディール及び事業提携情報
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆